Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Virta Health
The primary purpose of this research is to determine if GLA supplementation reduces weight regain over 24 months in Virta Health patients.
The secondary purpose is to determine the effect of GLA supplementation on diabetes-related outcomes.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age greater than or equal to 18 yrs
Patients referred to Virta Health by employers or insurers
Weight loss greater than or equal to 7% of initial weight and current BMI \> 25 kg/m2
Willing to take 3 supplement capsules daily
Able to understand study procedures and willing to provide informed consent
English-speaking
You may not be if
Patients who are pregnant or lactating
Patients who are taking or are prescribed orlistat
Clareo Health | Gamma-linolenic Acid Supplementation Study
